18F-FDG PET/CT characteristics of solitary fibrous tumour of the pleura: single institution experience

Zhao, Long; Wang, Huo-qiang; Shi, Jingyun

doi:10.1007/s12149-022-01723-x

Cited by 6 publications

(5 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Remarkably, it often presents either asymptomatically or with minimal pulmonary symptoms [ 4 , 5 ]. Around 50% of solitary fibrous tumors are discovered incidentally during chest imaging procedures like CXR or CT [ 6 ]. Despite their typically minimal symptoms, these tumors can invade cardiac tissue, leading to embolization and contributing to other critical conditions.…”

Section: Discussionmentioning

confidence: 99%

A Case of a Large and Rare Incidental Pleural Tumor in an Elderly Female

Mangal,

Hasso,

Obri

et al. 2023

Cureus

View full text Add to dashboard Cite

Solitary fibrous tumors are very rare in the pleura, and they are generally found incidentally. Even though they can potentially become malignant and metastasize, they have minimal clinical symptoms and can still be benign. Due to the low incidence of these tumors, there is no standard of therapy beyond surgical resection. We present an asymptomatic case of a large, rapidly expanding solitary fibrous tumor of the pleura in an elderly female.

show abstract

Section: Discussionmentioning

confidence: 99%

A Case of a Large and Rare Incidental Pleural Tumor in an Elderly Female

Mangal,

Hasso,

Obri

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…These modalities offer increased sensitivity and specificity, facilitating accurate tumour localisation and assessment of tumour biology [1,34]. The use of fluorodeoxyglucose positron emission tomography (FDG-PET) in the evaluation of SFTs and associated syndromes is crucial for accurate diagnosis and management [42,43]. However, it is essential to acknowledge the potential for false-negative results with FDG-PET, which may occur due to various factors.…”

Section: Long-term Follow-upmentioning

confidence: 99%

“…Several studies have highlighted the limitations of FDG-PET in detecting SFTs, particularly in cases of low-grade or indolent tumours. Therefore, while FDG-PET remains a valuable imaging modality in the evaluation of SFTs, clinicians should be aware of its limitations and consider complementary imaging modalities and histopathological assessments for comprehensive diagnostic evaluation [43][44][45].…”

Section: Long-term Follow-upmentioning

confidence: 99%

Addressing recurrent hypoglycaemia through thoracic surgical intervention: understanding Doege-Potter syndrome, a rarity in syndromes

Leivaditis,

Ehle,

Papatriantafyllou

et al. 2024

Arch Med Sci Atheroscler Dis

View full text Add to dashboard Cite

Doege-Potter syndrome (DPS), a rare paraneoplastic phenomenon characterised by non-islet cell tumour hypoglycaemia (NICTH), presents clinicians with intricate diagnostic and therapeutic challenges. This comprehensive review consolidates current understanding, clinical presentations, diagnostic modalities, therapeutic interventions, and emerging trends in managing DPS. The pathophysiology of DPS revolves around dysregulated insulin-like growth factors (IGF), particularly IGF-2, produced by mesenchymal tumours, notably solitary fibrous tumours (SFT). Clinical manifestations encompass recurrent hypoglycaemic episodes, often distinct from typical hypoglycaemia, with implications for insulin and counterregulatory hormone levels. Diagnosis necessitates a multidisciplinary approach integrating biochemical assays, imaging studies, and histopathological confirmation of the underlying neoplasm. Surgical resection remains the cornerstone of treatment, complemented by adjunctive therapies to manage persistent hypoglycaemia. Prognosis is influenced by successful tumour resection and long-term surveillance for recurrence. A patient-centred approach, incorporating supportive services and multidisciplinary care, is essential for optimal outcomes in individuals affected by DPS.

show abstract

“…Concurrently, 18 FDG-PET scanning is not routinely required in the preoperative assessment of pSFTs [45]. Recently, a single-institutional study suggested [46] that 18 FDG-PET scanning might have a role in stratifying the clinical behavior of pSFTs, identifying those with a more aggressive or malignant component. Yeom and colleagues [47] retrospectively reviewed preoperative CT and 18 FDG-PET images of pathologically proven pSFTs and reported that morphological and metabolic features might help clinicians in the differential diagnosis; conversely, they could not predict the biological behavior of these neoplasms, but found a significantly higher standard uptake value (SUV) in patients with a malignant pSFT.…”

Section: Surgical Management In the Treatment Of Psft 61 Preoperative...mentioning

confidence: 99%

Surgery for Solitary Fibrous Tumors of the Pleura: A Review of the Available Evidence

Bertoglio,

Querzoli,

Kestenholz

et al. 2023

Cancers

View full text Add to dashboard Cite

Solitary fibrous tumors of the pleura (pSFT) are a relatively rare neoplasms that can arise from either visceral or parietal pleura and may have different aggressive biological behaviors. Surgery is well known to be the cornerstone of the treatment for pSFT. We reviewed the existing literature, focusing on the role of surgery in the management and treatment of pSFT. All English-written literature has been reviewed, focusing on those reporting on the perioperative management and postoperative outcomes. Surgery for pSFT is feasible and safe in all experiences reported in the literature, but surgical approaches and techniques may vary according to the tumor dimensions, localization, and surgeons’ skills. Long-term outcomes are good, with a 10-year overall survival rate of more than 70% in most of the reported experiences; on the other hand, recurrence may happen in up to 17% of cases, which occurs mainly in the first two years after surgery, but case reports suggest the need for a longer follow-up to assess the risk of late recurrence. Malignant histology and dimensions are the most recognized risk factors for recurrence. Recurrence might be operated on in select patients. Surgery is the treatment of choice in pSFT, but a radical resection and a careful postoperative follow-up should be carried out.

show abstract

18F-FDG PET/CT characteristics of solitary fibrous tumour of the pleura: single institution experience

Cited by 6 publications

References 27 publications

A Case of a Large and Rare Incidental Pleural Tumor in an Elderly Female

A Case of a Large and Rare Incidental Pleural Tumor in an Elderly Female

Addressing recurrent hypoglycaemia through thoracic surgical intervention: understanding Doege-Potter syndrome, a rarity in syndromes

Surgery for Solitary Fibrous Tumors of the Pleura: A Review of the Available Evidence

Contact Info

Product

Resources

About